Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Leukemia 1Exanthema 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 2daratumumab 2Dexamethasone 2Bortezomib 2prednylidene 1pegaspargase 1nelarabine 1merphos 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1capivasertib 1calaspargase pegol 1auricularum 1Vincristine 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Radiation 1Prednisone 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Medrol Veriderm 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × capivasertib × Clear all
NCT07175415 2025-09-16

HEM-iSMART E

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡